Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.46 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8661726 | 0.86 | XPO1 (0.49) | HTTHPGDALDH1A1PTGS1PTGS2 | |
| SCHEMBL5823579 | 0.84 | ACHE (0.56) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL29755788 | 0.83 | IAPP (0.50) | HTTHPGDALDH1A1PTGS1PTGS2 | |
| SCHEMBL10907538 | 0.83 | IAPP (0.50) | HTTHPGDALDH1A1PTGS1PTGS2 | |
| SCHEMBL30249555 | 0.82 | ACHE (0.55) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL11305964 | 0.82 | ACHE (0.55) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL742786 | 0.82 | ACHE (0.55) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL5000889 | 0.82 | ACHE (0.55) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL11305967 | 0.82 | ACHE (0.55) | PTGS1KMT2AMAPTPTPN1 | |
| SCHEMBL24074926 | 0.80 | HSPA5 (0.43) | HTTHSPA5HPGDALDH1A1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111718910-B | FAD-dependent oxidase Ma-1 in Diels-Alder adduct anabolic pathway and application | 中国中医科学院中药研究所（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-122059808-A | Method for selectively synthesizing isopentenyl phenol compounds | 兰州石化职业技术大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-4630558-A2 | TARGETED TREATMENT OF SPLICEOPATHY-INDUCED NEUROLOGICAL DISORDERS | Auttx, LLC (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20250290074-A1 | TARGETED TREATMENT OF SPLICEOPATHY-INDUCED NEUROLOGICAL DISORDERS | AUTTX LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-20240317660-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY PHENYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2024-09-26 | — | — | US | disclosed |
| WO-2024124203-A2 | TARGETED TREATMENT OF SPLICEOPATHY-INDUCED NEUROLOGICAL DISORDERS | AUTTX, LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| CN-118047788-A | Isopentenyl phenolic compound, and preparation method and application thereof | 中国医药工业研究总院有限公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-4359375-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY PHENYL COMPOUNDS | McMaster University (CA) | 2024-05-01 | — | — | EP | disclosed |
| CN-117942270-A | Preparation method and application of high-stability repair anti-aging liposome | 上海百雀羚生物科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240024403-A1 | Compositions and Methods for Managing Weight | UNIGEN, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| WO-2007017168-A1 | PROCESS FOR THE PREPARATION OF UBIHYDROQUINONES AND UBIQUINONES | DSM IP ASSETS B.V. (NL) | 2007-02-15 | — | — | WO | disclosed |
| US-20060247307-A1 | Novel transcriptional factor, process for producing the same and use thereof | NRL PHARMA, INC. (JP) | 2006-11-02 | — | — | US | disclosed |
| WO-2006034392-A9 | THERAPEUTIC QUINONES | UNIV MINNESOTA (US) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006034392-A2 | THERAPEUTIC QUINONES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1616856-A1 | NOVEL TRANSCRIPTIONAL FACTOR, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | NRL Pharma, Inc. (JP) | 2006-01-18 | — | — | EP | disclosed |
| EP-0069069-B1 | POLYMERISABLE COMPOSITIONS AND POLYMERISATION PRODUCTS RESULTING THEREFROM | CIBA-GEIGY AG (CH) | 1988-03-02 | — | — | EP | disclosed |
| EP-0087454-B1 | BINDER BASED ON MIXED CONDENSATES OF EPOXY RESINS AND RESOLS AS WELL AS OF AMINES, METHOD FOR THE PREPARATION THEREOF AND METHOD FOR DEPOSITION BY ELECTROPHORESIS AS WELL AS THE USE THEREOF IN A ELECTROPHORESIS BATH | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-10-23 | — | — | EP | disclosed |
| US-4481311-A | Binders based on co-condensates of epoxy resins and resols with amines a process for their preparation and for electrophoretic deposition, and an electrophoresis bath | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-11-06 | — | — | US | disclosed |
| EP-0087454-A1 | BINDER BASED ON MIXED CONDENSATES OF EPOXY RESINS AND RESOLS AS WELL AS OF AMINES, METHOD FOR THE PREPARATION THEREOF AND METHOD FOR DEPOSITION BY ELECTROPHORESIS AS WELL AS THE USE THEREOF IN A ELECTROPHORESIS BATH. | HOECHST AG (DE) | 1983-09-07 | — | — | EP | disclosed |
| WO-1983000872-A1 | BINDER BASED ON MIXED CONDENSATES OF EPOXY RESINS AND RESOLS AS WELL AS OF AMINES, METHOD FOR THE PREPARATION THEREOF AND METHOD FOR DEPOSITION BY ELECTROPHORESIS AS WELL AS ELECTROPHORESIS BATH | HOECHST AG (DE) | 1983-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247307-A1 | Novel transcriptional factor, process for producing the same and use thereof | PPARG, NR1I2, NR1H2 | HTT 4073/4885HSPA5 3185/4885HPGD 1836/4885 |
| US-20240317660-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY PHENYL COMPOUNDS | ADH1A, AHR, ADH1C | HTT 655/4885HSPA5 2081/4885HPGD 607/4885 |
| US-20240024403-A1 | Compositions and Methods for Managing Weight | LIPE, PNLIP, LIPC | HTT 2505/4885HSPA5 3535/4885HPGD 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.